Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1979 Oct 13;2(6195):893–895. doi: 10.1136/bmj.2.6195.893

De novo acute infection and reactivation of hepatitis B virus in established cirrhosis.

A Theodossi, S P Wilkinson, B Portmann, Y White, A L Eddleston, R Williams, A J Zuckerman
PMCID: PMC1596746  PMID: 519221

Abstract

Five patients with cirrhosis proved by biopsy had clinical, biochemical, and serological evidence of an acute hepatitis B infection. In two the illness was fulminant and led to death. Only one patient completely recovered. Serological markers for the hepatitis B virus were absent before the onset of the acute illness in four patients, which suggested that a de novo infection had been acquired as a result of recent transfusions of blood or blood products. The fifth patient, who had Goodpasture's syndrome, had antibody to the core of hepatitis B virus, indicating previous exposure to the virus; his acute hepatitis may have been related to immunosuppressive drug treatment, which may have reactivated a dormant virus infection. Thus an acute type B viral hepatitis due to either a de novo or a reactivated infection may be superimposed on cirrhosis.

Full text

PDF
893

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hoofnagle J. H., Gerety R. J., Barker L. F. Antibody to hepatitis-B-virus core in man. Lancet. 1973 Oct 20;2(7834):869–873. doi: 10.1016/s0140-6736(73)92004-7. [DOI] [PubMed] [Google Scholar]
  2. Hoofnagle J. H., Seeff L. B., Bales Z. B., Zimmerman H. J. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med. 1978 Jun 22;298(25):1379–1383. doi: 10.1056/NEJM197806222982502. [DOI] [PubMed] [Google Scholar]
  3. Koziol D. E., Alter H. J., Kirchner J. P., Holland P. V. The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg. J Immunol. 1976 Dec;117(6):2260–2262. [PubMed] [Google Scholar]
  4. Nagington J. Reactivation of hepatitis b after transplantation operations. Lancet. 1977 Mar 12;1(8011):558–560. doi: 10.1016/s0140-6736(77)91995-x. [DOI] [PubMed] [Google Scholar]
  5. Portmann B., Galbraith R. M., Eddleston A. L., Zuckerman A. J., Williams R. Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods. Gut. 1976 Jan;17(1):1–9. doi: 10.1136/gut.17.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Wands J. R., Chura C. M., Roll F. J., Maddrey W. C. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology. 1975 Jan;68(1):105–112. [PubMed] [Google Scholar]
  7. Wyke R. J., Tsiquaye K. N., Thornton A., White Y., Portmann B., Das P. K., Zuckerman A. J., Williams R. Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet. 1979 Mar 10;1(8115):520–524. doi: 10.1016/s0140-6736(79)90945-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES